We are live on ! Find out more
HCMT

Highland Capital Management (Tennessee) Portfolio holdings

AUM $2.17B
1-Year Est. Return 54.74%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+54.74%
3 Year Est. Return
+141.9%
5 Year Est. Return
+171.7%
10 Year Est. Return
+576.48%
AUM
$536M
AUM Growth
+$22.2M
Cap. Flow
-$205K
Cap. Flow %
-0.04%
Top 10 Hldgs %
26.98%
Holding
152
New
17
Increased
45
Reduced
70
Closed
1

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.06M
2
IVZ icon
Invesco
IVZ
+$2.55M
3
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$1.36M
4
BND icon
Vanguard Total Bond Market
BND
+$1.29M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$1.01M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$5.32M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.59M
3
BKLN icon
Invesco Senior Loan ETF
BKLN
+$1.54M
4
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$1.05M
5
AFL icon
Aflac
AFL
+$876K

Sector Composition

Rank Sector Weight
1 Healthcare 13.23%
2 Technology 13.1%
3 Energy 10.61%
4 Industrials 9.49%
5 Financials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FAX
151
abrdn Asia-Pacific Income Fund
FAX
$604M
$199K 0.04%
5,275
– –
TGT icon
152
Target
TGT
$69.2B
– –
-87,875
Closed -$5.32M
3 4 5 6
7

Similar funds

ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Highland Capital Management (Tennessee)'s Q2 2014 Portfolio in Review

As of Q2 2014, Highland Capital Management (Tennessee) held 152 positions worth $536M, up 4.3% from $514M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Highland Capital Management (Tennessee)'s Q2 2014 filing shows 17 new, 45 increased, 70 reduced and 1 closed positions. Its largest new stake was Gilead Sciences: 39,314 shares worth $3.26M. The largest sale was Target, an estimated $5.32M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Energy.

  • Highland Capital Management (Tennessee)'s largest Q2 2014 buy was Gilead Sciences: 39,314 shares worth $3.26M.
  • Highland Capital Management (Tennessee) added most to State Street SPDR Portfolio Short Term Corporate Bond ETF in Q2 2014, an estimated $1.36M increase.
  • Highland Capital Management (Tennessee)'s biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $2.59M.
  • Highland Capital Management (Tennessee) fully exited Target in Q2 2014, selling an estimated $5.32M.
  • Highland Capital Management (Tennessee)'s ten largest holdings make up 27% of its $536M portfolio in Q2 2014.
  • Highland Capital Management (Tennessee) opened 17 new positions and closed 1 in Q2 2014.
  • Highland Capital Management (Tennessee)'s portfolio value rose 4.3% quarter-over-quarter to $536M.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2014, filed 22 Jul 2014.